The rate of invasive pneumococcal disease (IPD) in children too old to be vaccinated (≈1.5 – 10 years old) fell by 33% over a five-year period following the introduction of PCV-10 vaccines in Finland. The rate of IPD caused by serotypes in the vaccine fell by 58% in these children.
Full Citation:
Rinta-Kokko H, Palum AA, Auranen K et al.. 2018. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland. Vaccine. 36(15).
Title of Article: Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland
Author(s): Rinta-Kokko H, Palum AA, Auranen K et al.
Publication Year: 2018
Publication Name: Vaccine
Publication Volume: 36(15)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/29526371
DOI (Digital Object Identifier): 10.1016/j.vaccine.2018.03.001
Topics: Health
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Countries: Finland
WHO Regions: Europe